Cargando…
Characterization of ShigETEC, a Novel Live Attenuated Combined Vaccine against Shigellae and ETEC
Background: Shigella spp. and enterotoxigenic Escherichia coli (ETEC) remain the two leading bacterial causes of diarrheal diseases worldwide. Attempts to develop preventive vaccines against Shigella and ETEC have not yet been successful. The major challenge for a broad Shigella vaccine is the serot...
Autores principales: | Harutyunyan, Shushan, Neuhauser, Irene, Mayer, Alexandra, Aichinger, Michael, Szijártó, Valéria, Nagy, Gábor, Nagy, Eszter, Girardi, Petra, Malinoski, Frank J., Henics, Tamás |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712393/ https://www.ncbi.nlm.nih.gov/pubmed/33207794 http://dx.doi.org/10.3390/vaccines8040689 |
Ejemplares similares
-
Evaluation of the Safety, Tolerability and Immunogenicity of ShigETEC, an Oral Live Attenuated Shigella-ETEC Vaccine in Placebo-Controlled Randomized Phase 1 Trial
por: Girardi, Petra, et al.
Publicado: (2022) -
Anti-Toxin Responses to Natural Enterotoxigenic Escherichia coli (ETEC) Infection in Adults and Children in Bangladesh
por: Girardi, Petra, et al.
Publicado: (2023) -
Vaccines for the prevention of diarrhea due to cholera, shigella, ETEC and rotavirus
por: Das, Jai K, et al.
Publicado: (2013) -
Immunogenic evaluation of chimeric recombinant protein against ETEC, EHEC and Shigella
por: Khalouie, Farzane, et al.
Publicado: (2017) -
Considerations for using ETEC and Shigella disease burden estimates to guide vaccine development strategy
por: Hosangadi, Divya, et al.
Publicado: (2019)